Compositions and methods for therapy and diagnosis of prostate cancer

US7074898B2 · kind B2 · utility

Assignee

• CORIXA CORPORATION · US

Inventors

• Jiangchun Xu · Bellevue, US
• Davin C. Dillon · Issaquah, US
• Jennifer Mitcham · Redmond, US
• Susan Harlocker · Foster City, US
• Yuqiu Jiang · Kent, US
• Steven G. Reed · Bellevue, US
• Michael D. Kalos · Philadelphia, US
• Gary Fanger · Mill Creek, US
• Marc Retter · Carnation, US
• John Stolk · Bothell, US
• Craig Day · Seattle, US

Key dates

• Filing date: Dec 5, 2001
• Grant date: Jul 11, 2006
• Expiry date: Feb 19, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2760/16222
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compositions and methods for the therapy and diagnosis of cancer, such as prostate cancer, are disclosed. Compositions may comprise one or more prostate-specific proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a prostate-specific protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as prostate cancer. Diagnostic methods based on detecting a prostate-specific protein, or mRNA encoding such a protein, in a sample are also provided.